C.R. Bard, Inc.  

(Public, NYSE:BCR)   Watch this stock  
Find more results for Automatic Power, Inc.�
139.49
+0.23 (0.17%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 138.51 - 140.60
52 week 97.61 - 150.13
Open 138.89
Vol / Avg. 555,554.00/842,437.00
Mkt cap 10.80B
P/E 16.32
Div/yield 0.21/0.60
EPS 8.55
Shares 77.45M
Beta 0.53
Inst. own 91%
Apr 22, 2014
Q1 2014 C. R. Bard, Inc. Earnings Conference Call - 5:00PM EDT - Add to calendar
Apr 22, 2014
Q1 2014 C. R. Bard, Inc. Earnings Release - 4:00PM EDT - Add to calendar
Apr 16, 2014
C. R. Bard, Inc. 2014 Annual Shareholder Meeting
Apr 8, 2014
C. R. Bard, Inc. at Needham Healthcare Conference
Mar 4, 2014
C. R. Bard, Inc. at Raymond James Financial Inc Institutional Investors Conference
Feb 24, 2014
C. R. Bard, Inc. at Citi Global Healthcare Conference - Webcast
Jan 30, 2014
Q4 2013 C. R. Bard, Inc. Earnings Conference Call - Webcast
Jan 30, 2014
Q4 2013 C. R. Bard, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 84.35% 22.62%
Operating margin 114.25% 34.38%
EBITD margin - 26.02%
Return on average assets 58.16% 15.01%
Return on average equity 146.34% 33.75%
Employees 13,000 -
CDP Score - -

Address

730 Central Avenue
MURRAY HILL, NJ 07974
United States - Map
+1-908-2778000 (Phone)
+1-908-2778412 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

C. R. Bard, Inc. (Bard) is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. As of December 31, 2011, the Company sold a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities on a global basis. The Company participates in the markets for vascular, urology, oncology and surgical specialty products. Bard also has a product group of other products. Through subsidiaries and a joint venture, Bard markets its products to customers in over 100 countries outside the United States. The Company�s principal international markets were in Europe and Japan as of December 31, 2011. On November 10, 2011, Bard acquired Medivance, Inc. On December 16, 2011, the Company acquired Lutonix, Inc.

Officers and directors

Timothy M. Ring Chairman of the Board, Chief Executive Officer
Age: 55
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John H. Weiland President, Chief Operating Officer, Director
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Christopher S Holland Chief Financial Officer, Senior Vice President
Age: 46
Bio & Compensation  - Reuters
John A. DeFord Ph.D. Senior Vice President - Science, Technology and Clinical Affairs
Age: 51
Bio & Compensation  - Reuters
Gary D. Dolch Senior Vice President - Quality, Regulatory and Medical Affairs
Age: 65
Bio & Compensation  - Reuters
Jean F. Holloway Vice President, General Counsel, Secretary
Age: 56
Bio & Compensation  - Reuters
Frank Lupisella Jr. Vice President, Controller
Age: 52
Bio & Compensation  - Reuters
Bronwen K. Kelly Vice President - Human Resources
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Sharon M. Alterio Group Vice President
Age: 50
Bio & Compensation  - Reuters
Jim C. Beasley Group Vice President
Age: 49
Bio & Compensation  - Reuters